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Adiponectin is an adipocyte-secreted protein involved in a variety of metabolic processes, including glucose
regulation and fatty acid catabolism. We conducted a genome-wide association study to investigate the gen-
etic loci associated with plasma adiponectin in 1776 unrelated Filipino women from the Cebu Longitudinal
Health and Nutrition Survey (CLHNS). Our strongest signal for adiponectin mapped to the gene CDH13
(rs3865188, P ≤ 7.2 3 10216), which encodes a receptor for high-molecular-weight forms of adiponectin.
Strong association was also detected near the ADIPOQ gene (rs864265, P 5 3.8 3 1029) and at a novel
signal 100 kb upstream near KNG1 (rs11924390, P 5 7.6 3 1027). All three signals were also observed in
1774 young adult CLHNS offspring and in combined analysis including all 3550 mothers and offspring
samples (all P ≤ 1.6 3 1029). An uncommon haplotype of rs11924390 and rs864265 (haplotype frequency 5
0.050) was strongly associated with lower adiponectin compared with the most common C–G haplotype in
both CLHNS mothers (P 5 1.8 3 10225) and offspring (P 5 8.7 3 10232). Comprehensive imputation of 2653
SNPs in a 2 Mb region using as reference combined CHB, JPT and CEU haplotypes from the 1000
Genomes Project revealed no variants that perfectly tagged this haplotype. Our findings provide the first
genome-wide significant evidence of association with plasma adiponectin at the CDH13 locus and identify
a novel uncommon KNG1–ADIPOQ haplotype strongly associated with adiponectin levels in Filipinos.
INTRODUCTION
Adiponectin, an adipokine secreted by adipocytes, is believed
to play important roles in various metabolic processes, includ-
ing glucose regulation and fatty acid catabolism (1). Plasma
adiponectin level is negatively correlated with body mass
index (BMI), glucose, insulin and triglyceride levels and is
positively associated with high-density lipoprotein cholesterol
(HDL-C) concentration and insulin-stimulated glucose dispo-
sal (1). Animal studies have reported that administration of
adiponectin attenuated insulin resistance and improved endo-
thelial dysfunction (2,3). The protective effect of adiponectin
is further supported by epidemiological studies in which indi-
viduals with obesity, type 2 diabetes and coronary artery
disease had decreased circulating adiponectin concentrations
(4,5). Therefore, hypoadiponectinemia has been suggested as
an independent risk factor for metabolic syndrome and may
lead to obesity, type 2 diabetes and atherosclerosis (6,7).
Circulating adiponectin level is under substantial genetic
influence. An estimated 30–70% of the variability in plasma
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adiponectin is explained by genetic variation (8–10).
Genome-wide linkage scans for adiponectin level produced
linkage signals, but replications were inconsistent across
different ethnic populations (8–10). Encoding the adiponectin
protein, the gene ADIPOQ has been widely investigated for
variants associated with circulating adiponectin. Several
SNPs including rs17300539 (211391G.A), rs2241766
(+45T.G) and rs1501299 (+276G.T) have been reproduci-
bly reported to be associated with circulating adiponectin
(11–16). Two reports suggested the presence of distinct
association signals for adiponectin levels represented by
5′-promoter SNP rs17300539 and either rs6773957 (17) or
rs182052 (18), and a gene-wide tagSNP investigation revealed
that two haplotype blocks mapping to the ADIPOQ promoter
and the relevant exons showed association with adiponectin
(19). Only limited evidence has been provided for the func-
tional relevance of these SNPs (20,21), and the common
genetic variants identified thus far explain only a fraction of
the estimated heritability for adiponectin (22).
Genome-wide association studies (GWAS) provide a more
complete characterization of common genetic determinants
across the genome. The first GWAS for adiponectin, con-
ducted in a population of northern and western European
origin, confirmed the strong association with variants in
ADIPOQ and reported initial evidence of association with
CDH13 (rs7195409, P ¼ 2.0 × 1025), although the latter
finding did not reach a level of genome-wide significance
(23). A recent meta-analysis of three GWAS revealed a new
locus, ARL15 (rs4311394, P ¼ 2.9 × 1028), and provided
further evidence that variants at ARL15 may be associated
with risk of type 2 diabetes in European populations (24).
The evidence for loci associated with circulating adiponectin
remains unclear in populations of non-European ancestry.
Therefore, the primary goal of this study was to perform a
GWAS to investigate SNP associations with plasma adiponec-
tin level in 1776 Filipino mothers from the Cebu Longitudinal
Health and Nutrition Survey (CLHNS). We also genotyped
selected SNPs and tested their association with adiponectin
concentration in 1774 young adult offspring of the CLHNS
mothers to test evidence in both sexes and in a younger
Asian population.
RESULTS
GWAS results in CLHNS mothers
A GWAS for plasma adiponectin in 1776 CLHNS women
(Table 1) showed 38 SNPs associated at P , 1026 that clus-
tered in three chromosome regions. The observed genomic
control inflation factor (lGC) was 1.03, suggesting no substan-
tial population stratification among the CLHNS mothers
sample (Fig. 1). The strongest signal mapped to CDH13
locus on chromosome 16 (rs3865188, P ¼ 7.2 × 10216) and
two signals were located on chromosome 3, near ADIPOQ
(rs864265, P ¼ 3.8 × 1029) and 100 kb upstream of
ADIPOQ near KNG1 (rs11924390, P ¼ 7.6 × 1027). Con-
ditioning on rs3865188, the remaining 22 nearby CDH13
SNPs showed no evidence for a secondary signal (P . 0.13,
Supplementary Material, Fig. S1). Conditional analysis for
SNPs within the KNG1–ADIPOQ gene region on
chromosome 3 showed that the two nearby loci were not com-
pletely independent (Supplementary Material, Fig. S2). In
models accounting for the ADIPOQ variant rs864265, the
strength of association slightly increased for the KNG1 SNP
rs11924390 (conditioned P ¼ 8.7 × 1028), but was greatly
attenuated for other ADIPOQ variants (P . 0.13). Similarly,
when the KNG1 variant rs11924390 was included in the stat-
istical model, the strength of association for the ADIPOQ SNP
rs864265 became more significant (conditioned P ¼ 4.4 ×
10210), whereas the association strength with other KNG1
SNPs was attenuated (P . 0.53).
We next tested whether these associations with adiponectin
were affected by adjustment for waist circumference. The
association became stronger for CDH13 (P ¼ 4.1 × 10221)
and ADIPOQ (P ¼ 9.2 × 10211), but did not change substan-
tially for KNG1 (P ¼ 2.4 × 1026). These findings may indi-
cate that adjusting for waist circumference removes an
independent source of variation in adiponectin levels.
Follow-up genotyping results in CLHNS mothers and
offspring samples
To confirm the evidence of the adiponectin association based
on imputed SNPs, we directly genotyped CDH13 rs3865188
and KNG1 rs11924390 in 1776 CLHNS mothers. Compared
with the original association based on imputed SNPs, the evi-
dence remained comparably significant when using exper-
imentally determined genotypes (rs3865188 P ¼ 3.8 ×
10216; rs11924390 P ¼ 2.2 × 1026, Table 2); high quality
imputed genotypes were analyzed for rs864265 (MACH
r2 . 0.99, see also Materials and Methods).
We also genotyped the three index SNPs in the CLHNS
young adult offspring (Table 1). We first examined the associ-
ation in a subgroup of the offspring sample consisting of 336
individuals whose mothers were not present in CLHNS
mothers GWAS sample. Significant association (Bonferroni
corrected P , 0.017, 0.05/3 tests) was observed for
rs3865188 (P ¼ 3.7 × 1026), rs864265 (P ¼ 5.1 × 1024) and
rs11924390 (P ¼ 0.0059) (Table 2). When all 1774 offspring
were included in the analysis, we observed significant evi-
dence of association for rs3865188 (P ¼ 2.3 × 10218),
rs864265 (P ¼ 1.3 × 10214) and rs11924390 (P ¼ 2.2 ×
1024) (Table 2). When the mother and offspring samples were
combined using a linear mixed effect model that accounted for
their relationships, the associations reached genome-wide sig-
nificance (rs3865188, P ¼ 4.1 × 10230; rs864265, P ¼ 1.4 ×
10219 and rs11924390, P ¼ 1.6 × 1029, Table 2).
Two-SNP haplotype effect of rs11924390 (KNG1) and
rs864265 (ADIPOQ) on plasma adiponectin
Given the close proximity of the KNG1 and ADIPOQ loci, we
performed haplotype analyses to investigate the association
between adiponectin and the specific two-SNP haplotypes
consisting of the lead SNPs at KNG1 (rs11924390) and
ADIPOQ (rs864265) in both the CLHNS mothers and the off-
spring. The effect on adiponectin of each additional copy of
the specific haplotype compared with the homozygote refer-
ence haplotype was assessed. The uncommon C–T haplotype
with a frequency of 0.050 was significantly associated with a
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decreased level of adiponectin compared with the most
common C–G haplotype in CLHNS mothers (P ¼ 1.8 ×
10225, Table 3). Similar findings of haplotype association
were observed in the 336 independent offspring (P ¼ 9.5 ×
10212) and in the entire set of 1774 offspring (P ¼ 8.7 ×
10232, Table 3). Further analyses that computed score stat-
istics provided significant evidence for an overall association
between haplotypes and adiponectin level (global P ¼ 1.1 ×
10227, 5.0 × 1024 and 5.9 × 10235 in CLHNS mothers, inde-
pendent offspring subgroup and all offspring, respectively).
In both mothers and offspring, the uncommon C–T haplotype
showed the strongest evidence of association, suggesting that
this haplotype is largely responsible for the observed associ-
ations between adiponectin and the individual SNPs. Compre-
hensive imputation of 2653 SNPs in a 2 Mb region using as
reference combined CHB, JPT and CEU haplotypes from
the 1000 Genomes Project revealed no variants that perfectly
tagged this haplotype (Supplementary Material, Fig. S3).
Adiponectin association with previously reported SNPs
We next examined whether associations in the CLHNS mother
sample replicated evidence for loci previously reported in
either candidate gene studies or GWAS (Table 4). Among
ADIPOQ variants identified by a candidate gene approach,
the widely reported promoter SNP rs17300539 (211391
G.A) with potential biological function (16) was monomor-
phic in the CLHNS mothers. Four other candidate gene var-
iants rs266729 (211377 C.G), rs2241766 (+45 T.G),
rs1501299 (+276 G.T) and rs1063537 (11,13,16) were mar-
ginally associated with adiponectin (P ¼ 0.018, 0.0077, 0.059
and 0.017, respectively). The GWAS SNP rs3774261 (23)
displayed significant association in the same direction in
CLHNS (P ¼ 7.0 × 1025). Although rs3774261 was in weak
LD with the ADIPOQ index SNP rs864265 (r2 ¼ 0.02 based
on HapMap CHB and JPT combined sample), reciprocal
conditional analyses suggested that adiponectin associations
with these variants are not independent (P for rs3774261 con-
ditional on rs864265 ¼ 0.066, Table 4; P for rs864265 con-
ditional on rs3774261 ¼ 2.4 × 1026). We did not replicate
associations with other GWAS SNPs (23,24) in ARL15
(rs4311394, P ¼ 0.53) and LYZL1 (rs1774950, P ¼ 0.73).
Notably, the most strongly associated CDH13 SNP reported
previously (rs7195409) (23) was not significantly associated
with adiponectin in the CLHNS mothers (P ¼ 0.16). The
strongest CDH13 SNP in the CLHNS mothers (rs3865188,
P ¼ 3.8 × 10216) exhibited only limited LD with rs7195409
(r2 ¼ 0 and D′ ¼ 0.06 in HapMap CHB and JPT combined
samples, Table 4).
Association of CDH13, ADIPOQ and KNG1 variants with
other metabolic-related traits
Consistent with findings in previous studies (25,26), plasma
adiponectin was highly correlated with other metabolic-related
traits including BMI, waist circumference, lipid profiles,
insulin and homeostasis model assessment (HOMA) index in
both the mothers and offspring (Supplementary Material,
Table S1). We next assessed the strongest adiponectin SNPs
at CDH13, ADIPOQ and KNG1 for their associations with
these related quantitative traits (Table 5). In the CLHNS
mothers, nominal associations were detected for CDH13
SNP rs3865188 with waist circumference (P ¼ 0.042) and
for ADIPOQ SNP rs864265 with triglycerides (P ¼ 0.047).
In the offspring, the G allele of ADIPOQ SNP rs864265 that
was associated with higher adiponectin level displayed nomin-
ally significant association with lower BMI (P ¼ 0.0086),
lower waist circumference (P ¼ 0.0066), lower insulin level
(P ¼ 0.0011), decreased HOMA-IR (P ¼ 0.0027) and
decreased HOMA-b (P ¼ 6.3 × 1024). The association
between rs864265 and HOMA-b remained significant after
Bonferroni correction for multiple testing (P , 0.0008, 0.05/
60 tests). After including adiponectin level as a covariate in
the model, the P-values for the associations with insulin,
HOMA-IR and HOMA-b remained nominally significant at
0.014, 0.026 and 0.0072, respectively, indicating that the
genetic effects of rs864265 on these traits may be partially
independent of adiponectin level.
DISCUSSION
The present study provides strong evidence of association with
adiponectin at CDH13, ADIPOQ and KNG1 that together
explain approximately 7.5 and 8.9% of the variability in
natural log-transformed adiponectin levels in 1776 Filipino
mothers and 1774 offspring, respectively. These data provide
the first genome-wide significant association at CDH13 and
compelling evidence for a novel uncommon haplotype near
ADIPOQ. Only nominally significant associations were
detected between ADIPOQ SNP rs864265 and multiple
metabolic-related traits in the CLHNS offspring, and the
effects of the associations with insulin, HOMA-IR and
HOMA-b were partially independent of adiponectin level.
Our strongest main effect signal mapped to the gene CDH13
on chromosome 16 and explained 3.7% of the variability in the
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Data are mean+SD, median (25th percentile, 75th percentile) or %.
Independent offspring (n ¼ 336) are a subgroup of individuals within the 1774
offspring sample whose mother was not included in the 1776 CLHNS mothers
cohort for GWA analysis.
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mothers and 4.3% in the offspring. The CDH13 gene encodes
the protein T-cadherin, which is a receptor for hexameric and
high-molecular-weight forms of adiponectin (27). T-cadherin
is highly expressed in endothelial and smooth muscle cells,
where it interacts with adiponectin and may protect vascular
endothelial cells from apoptosis (28). The association of adi-
ponectin with a SNP near CDH13 was recently reported in a
GWAS consisting of 2280 northern and western Europeans
(rs7195409, P ¼ 1.99 × 1025) (23), but we did not strongly
support association with that SNP in the CLHNS mothers
(P ¼ 0.16). Nonetheless, our data provided solid evidence
that the CDH13 locus is associated within adiponectin
levels. We observed a stronger and separate signal for adipo-
nectin in the CDH13 locus at rs3865188 (P ¼ 6.7 × 10216),
which resides in the gene’s promoter region, about 887 kb
upstream of the reported variant rs7195409. Very weak
linkage disequilibrium exists between rs7195409 and
rs3865188 (r2 ¼ 0, D′ ¼ 0.12 in CEU and r2 ¼ 0, D′ ¼ 0.06
in CHB and JPT combined samples), and conditional analyses
further supported their independence (P for rs3865188 con-
ditional on rs7195409 ¼ 5.0 × 10216; P for rs7195409 con-
ditional on rs3865188 ¼ 0.11). In addition, for the CDH13
variant rs11646213, which was previously reported in a
study of 4659 European individuals (P ¼ 0.10), we observed
stronger association in the 1776 CLHNS mothers (P ¼
1.27 × 1026) (29). Together, these results suggest that a
difference in genetic architecture between Europeans and
Asians within the CDH13 locus may explain our lack of repli-
cation of the previous SNP as well as our strong association
with other SNPs near the same gene.
The CLHNS samples also showed strong evidence for an
association between adiponectin and rs11924390 near the
gene KNG1, which has not been reported previously. KNG1
encodes two different proteins of high-molecular-weight kini-
nogen (HMWK) and low-molecular-weight kininogen via
alternative splicing. HMWK is essential for blood coagulation
and bradykinin release. A common variant (rs710446) was
recently reported to associate with activated partial thrombo-
plastin time (aPTT), which is related to the risk of thrombosis
and coagulation disorders (30). The SNP rs710446 is located
approximately 27 kb away from rs11924390 and we found
no association of this SNP with adiponectin in the CLHNS
mothers (P ¼ 0.45). The two SNPs are in weak pair-wise
linkage disequilibrium (r2 ¼ 0.07, D’ ¼ 0.59 based on
HapMap CHB and JPT combined samples), suggesting that
the aPTT signal in KNG1 is distinct from the adiponectin
signal we detected.
The gene region of ADIPOQ had strong prior evidence of
association with adiponectin level as a candidate gene and
was validated by recent GWA studies (11,16–18,
20,21,23,29). The Framingham Offspring Study, which sys-
tematically examined the associations with 22 SNPs that
captured all common variation at r2 . 0.8 across ADIPOQ
and its flanking regions, observed that adiponectin level was
Figure 1. Genome-wide association with plasma adiponectin in CLHNS mothers cohort. (A) Manhattan plot, (B) quantile–quantile plot of observed and
expected P-values for association with the adiponectin level. The observed genomic control inflation factor (lGC) was 1.03.
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significantly associated with SNPs in two different regulatory
regions, the 5′-promoter (rs17300539) and the 3′-untranslated
regions (rs6773957) (17). A recent study dissecting the genetic
architecture of plasma adiponectin suggested that two
ADIPOQ variants (rs17300539 and rs182052) exhibited inde-
pendent association (18), and a recent GWAS of 4659 Euro-
pean individuals suggested association with at least nine
SNP groups near ADIPOQ (29). In the CLHNS samples, con-
ditional analyses suggest that common SNPs in or near the
ADIPOQ gene (chr3:188 032–188 070 kb, spanning 11 kb
up- and downstream of exons) likely represent a single
signal for plasma adiponectin (Supplementary Material,
Fig. S2), although none of the SNPs imputed with high
quality perfectly tags the strongly associated rs11924390–
rs864265 haplotype.
Great efforts have been made by previous studies to pin-
point the functional variant(s) that influence circulating adipo-
nectin levels. Two ADIPOQ promoter SNPs, rs17300539
(211391G.A) and rs266729 (211377C.G), have been
investigated frequently in functional experiments
(9,11,12,31) due to their strong reproducible correlations
with circulating adiponectin and to the potential role of the
promoter region in regulating gene transcriptional activity.
In vitro data revealed a functional effect of rs17300539 on adi-
ponectin, suggesting that the A allele was likely to increase
ADIPOQ promoter activity and enhance transcription (31).
A subsequent study demonstrated that SNPs rs17300539,
rs266729 and a third ADIPOQ promoter variant rs16861194
(211426A.G) modulate gene transcription by altering the
DNA binding activity in mouse 3T3-L1 adipocytes; the
rs16861194 G allele substantially reduced basal promoter
and DNA binding activity, although the exact binding
factors remained largely unclear (21). Bioinformatic predic-
tion suggests that SNP rs266729 (211377C.G) alters the
sequence of one of four transcriptional stimulatory protein
(SP1) binding sites in the ADIPOQ promoter region (32).
Our results, however, did not support the importance of
these promoter SNPs in CLHNS mothers who reside in
Metro Cebu, Philippines. SNP rs17300539 is monomorphic
in mothers, while rs266729 showed only modest association
with plasma adiponectin (P ¼ 0.018), and no evidence for
association was found for rs16861194 (P ¼ 0.26). While
rs266729 shows similar minor allele frequencies between Eur-
opeans and Asians (CEU: G 0.30 and CLHNS: G 0.27), fre-
quencies differ for rs17300539 (CEU: A 0.08 and CLHNS:
A 0.00) and rs16861194 (CEU: G 0.07 and CLHNS: G
0.18), suggesting different genetic architecture in the
ADIPOQ promoter region between populations.
Given the differences in local genetic structure, the possible
functional relevance of other nearby genetic variants should be
considered. The SNP rs864265 (chr3: 188 036 986), located
5 kb upstream of the widely discussed ADIPOQ promoter
region and 16 kb upstream of the translation start site,
showed the strongest association with plasma adiponectin in
the CLHNS sample (P ¼ 3.8 × 1029). Perhaps more relevant,
our findings of association with the uncommon C–T haplotype
of the rs11924390 and rs864265 SNPs suggest that a func-
tional variant might be tagged by the uncommon haplotype.
Compared with the previously reported haplotypes that cover
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KNG1–ADIPOQ locus and suggests a more extensive gene
region where the potential causal SNP(s) may reside. We
investigated additional variation within 2 Mb (187–189 Mb)
flanking KNG1 and ADIPOQ by testing the association of
SNPs imputed based on 1000 Genomes Project Pilot data,
but no additional SNPs showed stronger association than
SNPs imputed based on HapMap (Supplementary Material,
Fig. S3). The failure to identify a stronger signal suggests
either that the 1000 Genomes Project Pilot did not include
the single functional variant, that such a variant was poorly
imputed and thus its association with adiponectin was inaccur-
ate or that more than one functional variant exists. Non-
synonymous amino acid substitutions may contribute to the
variation of circulating adiponectin by affecting the spatial
organization of the protein and interfering with post-
transcriptional modification, multimerization or interaction
of the protein with its receptors (16). Variants including
G84R, G90S, H111Y and R112C have been reported to be
associated with adiponectin level and suggested to be func-
tionally relevant (16,33,34). However, these variants were
rare in initial studies (MAF,0.02) and are not included as
HapMap or 1000 Genomes Project Pilot imputed SNPs.
Thus, their association with adiponectin level in the CLHNS
sample remains unknown.
In conclusion, this study expands our understanding of
genetic association with adiponectin in a population of
mostly non-European ancestry and underscores a difference
in the genetic architecture of plasma adiponectin levels
between Europeans and Asians. Our findings provide compel-
ling evidence of a strong association for plasma adiponectin
with the CDH13 locus. We also observed a haplotype associ-
ation with plasma adiponectin of an uncommon C–T
haplotype consisting of two variants at the KNG1–ADIPOQ
locus, which may motivate further studies to investigate poten-
tial functional variants and to elucidate the underlying biologi-
cal mechanisms.
MATERIALS AND METHODS
The original study population, study design and recruitment
protocols of the CLHNS have been described in detail pre-
viously (35). The CLHNS is a community-based birth cohort
study which originally enrolled 3327 pregnant women in
1983–1984, and the women and their offspring have since
been followed. In the 2005 survey, the available study
samples consisted of 1895 Filipino mothers and 1779 off-
spring. Among the mothers, we excluded 81 estimated first-
degree relatives, 14 participants without genotyping data and
24 individuals with missing adiponectin outcome or covari-
ates, and among the offspring we excluded one of each twin
pair (n ¼ 5). The final sample set included 1776 CLHNS
women and 1774 offspring, of which 336 independent off-
spring did not have a mother in the CLHNS mothers GWA
cohort and 1438 are members of offspring–mother pairs.
GWA SNP genotyping, quality control and genotype impu-
tation based on HapMap CEU + CHB + JPT using MACH
have also been previously described (36). Briefly, SNP geno-
typing was performed using the Affymetrix Genomewide
Human SNP Array 5.0, according to the manufacturer’s stan-
dard protocol. Genotyping calling was performed using Bird-
seed (Version 2). Genotyping was conducted on 1895 unique
CLHNS mothers samples, 40 CLHNS duplicates and 5
HapMap CEPH trios. Fourteen CLHNS samples were
excluded due to genotyping failure (n ¼ 10) or a ,97% call
rate (n ¼ 4). The final sample call rate was 99.6% in the
remaining 1881 CLHNS mother samples. In the marker
quality control for the initial 424 670 genotyping SNPs,
those with poor mapping, call rate ,90% and/or deviation
from Hardy–Weinberg equilibrium (P , 1026) were
removed from the follow-up imputation (n ¼ 13 287). An
additional 3277 SNPs were discarded due to three or more dis-
crepancies between genotypes in 40 duplicate pairs, Mende-
lian inheritance errors in five CEPH trios and/or three or
more genotype discrepancies with HapMap. We applied a
hidden Markov model algorithm implemented in MACH soft-
ware version 1.0 (37) to impute genotypes in CLHNS mothers
samples for 352 264 directly genotyped SNPs that were poly-
morphic in both the 60 CEU founders and the 89 combined
CHB + JPT HapMap samples. After exclusion of SNPs with
poor imputation quality (MACH r2 , 0.3) or with low
minor allele frequency (MAF ≤ 0.01), a total of 2 073 674
HapMap imputed SNPs were tested for association with
plasma adiponectin level in 1776 CLHNS mothers. Additional
imputation within 2 Mb gene region (187–189 Mb) of
KNG1–ADIPOQ locus was performed based on haplotypes
created from the 1000 Genomes Project pilot release
(August 2009) of CEU+CHB+JPT samples. Regional plots
were created using LocusZoom (38).
We constructed principal components (PCs) using the soft-
ware EIGENSOFT to capture population substructure among
CLHNS subjects (39). We assessed the association between
Table 3. Adiponectin association with haplotypes consisting of SNPs





CLHNS mothers (n ¼ 1776)
C G 0.450 Reference
T G 0.426 0.021 0.015 0.16
T T 0.074 0.064 0.028 0.020
C T 0.050 20.385 0.036 1.8E225
Independent CLHNS offspring (n ¼ 336)
C G 0.442 Reference
T G 0.405 0.027 0.030 0.38
T T 0.096 0.098 0.052 0.063
C T 0.056 20.504 0.071 9.5E212
All CLHNS offspring (n ¼ 1774)
C G 0.444 Reference
T G 0.427 0.004 0.013 0.78
T T 0.076 0.027 0.025 0.27
C T 0.052 20.386 0.032 8.7E232
The ‘haplo.glm’ function implemented in the ‘haplo.stats’ R package was used
to calculate the coefficient b and P-value for each haplotype compared with the
reference haplotype, which was set as the most common haplotype C–G. The
same covariates used for genotype analysis were applied in haplotype analysis.
Using the ‘haplo.score’ function implemented in the ‘haplo.stats’ R package,
the global P-values for association between haplotypes and adiponectin level
were 1.1 × 10227, 5.0 × 1024 and 5.9 × 10235 in CLHNS mothers,
independent offspring subgroup and all offspring sample, respectively.
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each of the first 10 PCs and the adiponectin level to identify
any potential ancestry explanatory PC; none were significantly
associated and thus no PCs were included as covariates in the
linear regression models for GWAS (All P . 0.06, Sup-
plementary Material, Table S2). The genomic control value
(lGC) was calculated to evaluate the type I error inflation
due to population stratification.
Plasma samples were analyzed for adiponectin with a com-
mercially available enzyme-linked immunosorbent assay
(R&D Systems #DY1065). All samples were assayed in dupli-
cate, and control samples were included with each assay to
monitor between-assay variation. The percent coefficient of
variation (SD/mean) for low, middle and high controls was
9.5, 9.6 and 7.8, respectively. Informed consent was obtained
from all CLHNS participants, and the study protocol was
approved by the University of North Carolina Institutional
Review Board for the Protection of Human Subjects.
Follow-up genotyping was performed for four SNPs
(rs3865188, rs11924390, rs864265 and rs17300539). The
first three SNPs were genotyped to validate their significant
associations with adiponectin observed in the mothers and
also to test for supporting evidence in the offspring. The
fourth SNP (rs17300539) was genotyped because it was a
reproducibly reported associated SNP for adiponectin, but
imputed genotypes were unavailable in the CLHNS mothers.
Three SNPs (rs17300539, rs3865188 and rs11924390) were
genotyped using TaqMan allelic discrimination (Applied Bio-
systems, Foster City, CA, USA) in both the CLHNS mothers
and offspring. The genotyping success rate was .97%, and
no discrepancies among 80 duplicate pairs were observed.
The ADIPOQ SNP rs864265 was successfully genotyped in
all 1774 CLHNS offspring using the Cardio-MetaboChip
(Illumina, San Diego, CA, USA). Direct genotype data for
rs864265 from the Cardio-MetaboChip were also available
for 85 (4.8%) mothers. Due to both the high imputation
quality of rs864265 (r2 . 0.99) and the high allele concor-
dance rate (.99.4%) between the Cardio-MetaboChip geno-
types and the posterior expected genotypes based on
HapMap imputed genotypes in the 85 mothers, rs864265
was not directly genotyped in the remaining 1691 mothers.
The imputed genotypes were then used in statistical analyses.
Adiponectin level was natural log-transformed (log-
adiponectin) to satisfy the model assumption of normally dis-
tributed residuals. GWA analyses were performed in Array
Studio software version 3.6 (Omicsoft Corporation, Research
Triangle Park, NC, USA). A multiple linear regression
model assuming an additive effect and adjusting for age,
age2, household assets, natural log-transformed household
income and menopausal status during the 2005 survey was
applied to test for the association between each SNP and
log-adiponectin in CLHNS mothers (Supplementary Material,
Table S2). A one degree-of-freedom likelihood ratio test was
used to examine the statistical significance.
In follow-up analyses, multiple linear regression models
were performed to test the association of three genotyped
SNPs (rs3865188, rs864265 and rs11924390) with
log-adiponectin in both the mother and offspring samples.
In the offspring, the analyses were adjusted for sex, household
























ADIPOQ 3 188,042,168 G.C G: 0.27 0.96 20.038 (0.016) 0.018 0.029 1.7E204 (16)
rs182052 ADIPOQ 3 188,043,476 A.G A: 0.45 1.00 20.017 (0.014) 0.22 0.057 9.1E204 (19)
rs17366568 ADIPOQ 3 188,053,147 G.A A: 0.03 0.98 0.034 (0.043) 0.44 0.001 0.54 (29)
rs2241766 (+45
T.G)
ADIPOQ 3 188,053,594 G.T G: 0.26 0.79 0.047 (0.017) 0.0077 ND 0.10 (13)
rs1501299
(+276 G.T)
ADIPOQ 3 188,053,825 G.T T:0.39 0.90 20.028 (0.015) 0.059 0.000 0.75 (13)
rs3774261 ADIPOQ 3 188,054,253 G.A G:0.37 1.00 20.056 (0.014) 7.0E205 0.019 0.066 (23)
rs6773957 ADIPOQ 3 188,056,407 G.A G:0.37 1.00 20.056 (0.014) 7.0E205 0.019 0.066 (23)
rs1063537 ADIPOQ 3 188,056,769 C.T T:0.22 0.96 20.041 (0.017) 0.017 0.020 0.12 (11)
rs4311394 ARL15 5 53,336,419 A.G G:0.44 0.99 0.009 (0.014) 0.53 ND ND (24)
rs1774950 LYZL1 10 82,085,093 T.C T:0.44 0.99 0.005 (0.014) 0.73 ND ND (23)
rs7195409 CDH13 16 82,085,093 A.G G:0.10 0.99 0.032 (0.023) 0.16 0 0.10 (23)
Analyses were adjusted for age, age2, household assets, natural log-transformed household income and menopausal status (n ¼ 1776). b (SE) indicates the effect
size and standard error of each additional copy of Allele 1 on natural log-transformed adiponectin level. The SNP rs17300539 (211391G.A) was monomorphic
in direct TaqMan genotyping.
aMACH r2 was applied to indicate the imputation quality of the imputed SNPs.
bLinkage disequilibrium (LD) measure r2 with the index SNP of each locus (ADIPOQ: rs864265 and CDH13: rs3865188), based on the HapMap CHB + JPT
combined sample.
cP-values for SNP association when conditional analysis was performed using the index SNP of each locus; ND, no data. Position for all SNPs is relative to NCBI
Build 36 assembly.
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assets and natural log-transformed household income. Age,
age2 and menopausal status that were used as covariates for
the analysis of CLHNS mothers were not included in offspring
analyses because the ages of all offspring were within 2 years
of each other (mean+SD ¼ 21.5+ 0.3, Table 1) and none
had reached menopause. In light of the relatedness between
mother–child pairs, follow-up analysis in offspring was first
conducted in a subgroup sample consisting of 336 CLHNS
offspring whose mothers were not included in the CLHNS
mother GWA samples. Partial correlations were determined
for each SNP to estimate the proportion of variation in
log-adiponectin explained by these genetic loci. To assess
the association on the combined sample of mothers and off-
spring, a general linear mixed model was used to account
for the correlation of adiponectin levels between mother–
child pairs due to shared genetic and environmental exposures.
Partial correlation analyses were used to evaluate the
relationship between adiponectin level and other metabolic-
related traits including BMI, waist circumference, triglycer-
ides, HDL-C, low-density lipoprotein cholesterol (LDL-C),
fasting glucose, insulin, homeostasis model assessment of
insulin resistance (HOMA-IR) and b-cell function
(HOMA-b). HOMA-IR was calculated as fasting glucose
(mmol/l) × fasting insulin (mU/ml)/22.5 while HOMA-b
was computed as 20 × fasting insulin (mU/ml)/[fasting
glucose (mmol/l) 2 3.5]. All traits except for waist circumfer-
ence were natural log-transformed before analyses. Multiple
linear regression models, accounting for the same covariates
as for the log-adiponectin analyses, were performed to test
for genotype effects on the metabolic-related traits. All ana-
lyses for follow-up association with log-adiponectin and
other metabolic-related traits were performed with SAS
version 9.2 (SAS Institute, Cary, NC, USA).
Haplotype analyses were performed using the ‘haplo.stat’ R
package. Haplotypes and haplotype frequencies were esti-
mated using the R function ‘haplo.em’. The association
between haplotypes and adiponectin was assessed using the
R function ‘haplo.glm’. An additive model was assumed, in
which the regression coefficient b represents the expected
change in natural log-transformed adiponectin level with
each additional copy of the specific haplotype compared
with the reference haplotype. The most common C–G haplo-
type of KNG1 (rs11924390)–ADIPOQ (rs864265) was set as
the reference haplotype. The R function ‘haplo.score’ was
used to compute the global score statistics to test the overall
association between haplotypes and adiponectin. The same
covariates used for genotype analysis were also applied in
the haplotype analysis models.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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